Central and Peripheral Airway Sites of Nitric Oxide Gas Exchange in COPD

被引:22
|
作者
Gelb, Arthur F. [1 ,3 ]
Taylor, Colleen Flynn
Krishnan, Anita
Fraser, Christine
Shinar, Chris M. [4 ]
Schein, Mark J. [2 ]
Osann, Kathryn [5 ]
机构
[1] Lakewood Reg Med Ctr, Div Pulm, Dept Med, Lakewood, CA USA
[2] Lakewood Reg Med Ctr, Dept Radiol, Lakewood, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Orange Coast Mem Med Ctr, Dept Performance Improvement & Patient Safety, Fountain Valley, CA USA
[5] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA
关键词
OBSTRUCTIVE PULMONARY-DISEASE; EXHALED AIR; FLOW-RATE; ALVEOLAR; ASTHMA; EXACERBATIONS; INFLAMMATION; HEALTHY; SPUTUM; NO;
D O I
10.1378/chest.09-1522
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: This study investigated sites of nitric oxide (NO) gas exchange and response to inhaled corticosteroids (ICS) in patients with COPD and varying extents of emphysema. Methods: This was a prospective, randomized, single-blind, crossover study in treated, stable, ex-smoking patients with COPD who were ICS and leukotriene receptor antagonists naive. Lung function, high-resolution thin-section CT scan of the lung, and exhaled NO were measured at 50, 100, 150, and 200 mL/s. Airway NO was adjusted for NO axial backdiffusion. Results: In 39 (18 women), clinically stable ex-smokers with COPD aged 73 +/- 9 years (mean +/- SD) on salmeterol 50 mu g (S50) bid, after 180 mu g aerosolized albuterol, FEV1 (L) was 52% +/- 12% predicted and FEV1/FVC was 55% +/- 6%. Compared with 20 (12 men) age-matched controls, 39 patients with COPD had normal large airway NO flux and small airway/alveolar NO. Subsequently, 19 patients with COPD (Group A) were randomized and continued on S50, and 20 (Group B) were randomized to fluticasone propionate 250 mu g (F250)/S50 bid for 86 +/- 16 days. Group A (S50) patients were then switched to F250/S50, and 12 of 19 completed 77 +/- 15 days; there was significant (P < .001) reduction only in the exhaled fraction of NO (FENO) at 50 mL/s and large airway NO flux. In 20 patients with COPD initially randomized to F250/S50 (Group B), after 57 +/- 22 days of S50 in 16 of 20 patients there was a significant (P = .04) increase only in (FENO) at 50 mL/s and large airway NO flux, which was not reduced after 60 +/- 23 days of fluticasone propionate 100 mu g (F100)/S50(P = .07). There was no correlation between NO gas exchange and CT-scored emphysema. Conclusions: In COPD, there was; normal NO gas exchange in both large and small airways/alveoli and only large airway NO flux was suppressed with F250/S50 but not F100/S50, despite varying extents of emphysema. Peripheral NO must be corrected for axial NO backdiffusion to avoid spurious conclusions. CHEST 2010; 137(3):575-584
引用
收藏
页码:575 / 584
页数:10
相关论文
共 50 条
  • [31] Axial distribution of nitric oxide airway production in asthma patients
    Van Muylem, Alain
    Kerckx, Yannick
    Michils, Alain
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2013, 185 (02) : 313 - 318
  • [32] Modeling pulmonary nitric oxide exchange
    George, SC
    Hogman, M
    Permutt, S
    Silkoff, PE
    JOURNAL OF APPLIED PHYSIOLOGY, 2004, 96 (03) : 831 - 839
  • [33] Exercise-induced bronchoconstriction alters airway nitric oxide exchange in a pattern distinct from spirometry
    Shin, Hye-Won
    Schwindt, Christina D.
    Aledia, Anna S.
    Rose-Gottron, Christine M.
    Larson, Jennifer K.
    Newcomb, Robert L.
    Cooper, Dan M.
    George, Steven C.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2006, 291 (06) : R1741 - R1748
  • [34] Response of exhaled nitric oxide to inhaled corticosteroids in patients with stable COPD: A systematic review and meta-analysis
    Lim, Chor-Shen
    Rani, Fauzi Abdul
    Tan, Lan-Eng
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (01) : 218 - 226
  • [35] Diagnostic performance of the measurement of nitric oxide in exhaled air in the diagnosis of COPD phenotypes
    Alcazar-Navarrete, B.
    Romero-Palacios, P. J.
    Ruiz-Sancho, A.
    Ruiz-Rodriguez, O.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2016, 54 : 67 - 72
  • [36] Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD
    Lehtimaki, L.
    Kankaanranta, H.
    Saarelainen, S.
    Annila, I.
    Aine, T.
    Nieminen, R.
    Moilanen, E.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (01) : 72 - 78
  • [37] Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations
    Antus, Balazs
    Barta, Imre
    Horvath, Ildiko
    Csiszer, Eszter
    RESPIROLOGY, 2010, 15 (03) : 472 - 477
  • [38] Measuring exhaled nitric oxide in COPD: from theoretical consideration to practical views
    Hogman, Marieann
    Pham-Ngoc, Ha
    Nguyen-Duy, Bo
    Ellingsen, Jens
    Hua-Huy, Thong
    Nguyen, Dinh Van
    Dinh-Xuan, Anh Tuan
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2024, 18 (12) : 1013 - 1024
  • [39] Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
    Donohue, James
    Earnhart, Samantha
    Herje, Nancy
    Dorinsky, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [40] Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway
    Chapman, Anna L. P.
    Morrissey, Brian M.
    Vasu, Vihas T.
    Juarez, Maya M.
    Houghton, Jessica S.
    Li, Chin-Shang
    Cross, Carroll E.
    Eiserich, Jason P.
    JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (02) : 84 - 92